Yup pretty pathetic sp/mc for a company with BTD on a potential blockbuster drug as well as some very strong preclinical work as a covid therapeutic. Obviously I agree with others who've said Don has done an absolutely lousy job of translating this into value creation for shareholders.  But you have to show investors you have a real business and he has clearly not done that. Hopefully Eversana can provide some meaningful guidance in that department.  I wonder if he is still having all that fun at work he was talking about awhile ago?  

Seller's through Anonymous and PI have been far and away the biggest net sellers this week, who knows maybe someone is driving the price down to get a good PP from Discount Don. Not really much volume/interest so easy to push the price around.